<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In 328 type 2 diabetic patients followed for 9.0 years (mean), we investigated whether <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e> and <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mp ids='MP_0001845'>inflammation</z:mp> (estimated from plasma markers) can explain the association between (micro)<z:mp ids='MP_0002871'>albuminuria</z:mp> and mortality </plain></SENT>
<SENT sid="1" pm="."><plain>Of the patients, 113 died </plain></SENT>
<SENT sid="2" pm="."><plain>Mortality was increased in patients with baseline <z:mp ids='MP_0002959'>microalbuminuria</z:mp> or macroalbuminuria (odds ratios as compared with normoalbuminuria, 1.78 [P &lt; 0.05] and 2.86 [P &lt; 0.01]) and in patients with soluble vascular cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule 1 in the third tertile and C-reactive protein in the second and third tertiles (odds ratios as compared with the first tertile, 2.05 [ P &lt; 0.01], and 1.80 [P &lt; 0.05] and 2.92 [ P &lt; 0.01]) </plain></SENT>
<SENT sid="3" pm="."><plain>These associations were mutually independent </plain></SENT>
<SENT sid="4" pm="."><plain>The mean yearly change in urinary albumin excretion was 9.4%; in <z:e sem="disease" ids="C0042974" disease_type="Disease or Syndrome" abbrv="">von Willebrand</z:e> factor, 8.1%; in tissue-type plasminogen activator, 2.8%; in soluble vascular cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule 1, 5.2%; in soluble E-selectin, -2.3%; in C-reactive protein, 3.8%; and in fibrinogen, 2.3% </plain></SENT>
<SENT sid="5" pm="."><plain>The longitudinal development of urinary albumin excretion was significantly and independently determined by baseline levels of and the longitudinal development of BMI, systolic blood pressure, serum <z:chebi fb="0" ids="16737">creatinine</z:chebi>, glycated <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> and plasma <z:e sem="disease" ids="C0042974" disease_type="Disease or Syndrome" abbrv="">von Willebrand</z:e> factor (baseline only), soluble E-selectin (baseline only), tissue-type plasminogen activator, C-reactive protein, and fibrinogen </plain></SENT>
<SENT sid="6" pm="."><plain>The longitudinal developments of markers of endothelial function and <z:mp ids='MP_0001845'>inflammation</z:mp> were interrelated </plain></SENT>
<SENT sid="7" pm="."><plain>In type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, increased urinary albumin excretion, <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e>, and <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mp ids='MP_0001845'>inflammation</z:mp> are interrelated processes that develop in parallel, progress with time, and are strongly and independently associated with risk of <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
</text></document>